Skip to content

13F-HR filed by Foresite Capital Management IV, LLC

Foresite Capital Management IV, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:23:50 UTC, with 6 holding rows worth $252,030,239.

Accession
0001104659-26-128376
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 6 entries on the cover page, a total value of $252,030,239 stated on the cover page (in dollars after the unit check, H1), rows summing to $252,030,239 with VALUE read as dollars as filed, 13F file number 028-18415. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PHARVARIS NVN69605108COMMON STOCK4,778,581$151,576,589dollars as filed
CYTOKINETICS INC23282W605COM NEW714,695$47,105,547dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock1,250,000$22,562,500dollars as filed
EIKON THERAPEUTICS INC282564103COMMON STOCK1,943,682$15,627,203dollars as filed
VERACYTE INC COM92337F107Stock200,000$9,208,000dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock160,000$5,950,400dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-128376this filing2026-11-16